ArticleEuropean heart journal open2026

Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes.

Carl J Lavie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.